PIA
INO icon

Piedmont Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Piedmont Investment Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-120
Closed -$6K – 1642
2018
Q2 		$6K Buy
+120
New +$6.62K ﹤0.01% 2038
2016
Q4 		– Sell
-13
Closed -$1.5K – 685
2016
Q3 		$1.5K Hold
13
– – ﹤0.01% 427
2016
Q2 		$1.49K Hold
13
– – ﹤0.01% 352
2016
Q1 		$1.4K Buy
13
+6
+86% +$463 ﹤0.01% 353
2015
Q4 		$571 Buy
+7
New +$557 ﹤0.01% 396

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Piedmont Investment Advisors's INO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Inovio Pharmaceuticals (INO) in Q3 2018, closing a stake of 120 shares — an estimated $6K sold.

Piedmont Investment Advisors first reported a position in INO in Q4 2015 and held it in 5 quarters. The position peaked at $6K in Q2 2018. 130 funds tracked by Wall St. Rank hold INO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Inovio Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 120 Inovio Pharmaceuticals shares in Q3 2018, an estimated $6K.
  • Piedmont Investment Advisors first reported a position in Inovio Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • Piedmont Investment Advisors's Inovio Pharmaceuticals position peaked at $6K in Q2 2018.
  • 130 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.